Cook and co-coworkers demonstrated the ability of luteolin to block the production of VEGF in human breast cancer cells (T47-D and BT-474) responsive to (natural and synthetic) progestins, both in vitro and in a xenograft model [28]. This evidence concerns the gene VEGFA and breast carcinoma.